| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T80 |
0-146 |
Sentence |
denotes |
Generally, patients with early-stage breast cancer undergo primary surgery (breast-conserving surgery or mastectomy) with or without radiotherapy. |
| T81 |
147-360 |
Sentence |
denotes |
Following local treatment, adjuvant systemic therapy may be recommended based on primary tumor characteristics, such as tumor size, stage, lymph node involvement, ER/PR status, and expression of the HER2 receptor. |
| T82 |
361-471 |
Sentence |
denotes |
However, in the pandemic period, some priorities have also changed in the treatment of invasive breast cancer. |
| T83 |
472-591 |
Sentence |
denotes |
ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic. |
| T84 |
592-744 |
Sentence |
denotes |
The decision of selection between Tamoxifen and aromatase inhibitors depends on patients’ premenopausal or postmenopausal situation and hormonal status. |
| T85 |
745-886 |
Sentence |
denotes |
If the patient is not postmenopausal, sequential evaluation of hormonal status is recommended to consider an alternative endocrine agent.[12] |
